---
title: "| RESEARCH PROTOCOL\n| \n| Comparison of feature selection pipelines to develop parsimonious patient-level prediction models \n"
fontsize: 12pt
geometry: margin=1in
output:
  bookdown::html_document2:
    df_print: paged
    toc: yes
    toc_depth: 2
    toc_float: yes
    number_sections: yes
    number_tables: yes
    css: "style.css"
  bookdown::pdf_document2:
    keep_tex: yes
    latex_engine: xelatex
    md_extensions: +raw_attribute
    number_sections: yes
    # citation_package: natbib
    includes:
      before_body: title.tex
  bookdown::word_document2:
    toc: yes
header-includes:
- \usepackage[numbers,sort&compress]{natbib}
- \usepackage{booktabs}
- \usepackage{longtable}
- \usepackage{array}
- \usepackage{multirow}
- \usepackage{wrapfig}
- \usepackage{float}
- \usepackage{colortbl}
- \usepackage{pdflscape}
- \usepackage{tabu}
- \usepackage{threeparttable}
- \usepackage{threeparttablex}
- \usepackage[normalem]{ulem}
- \usepackage{makecell}
- \usepackage{caption}
- \usepackage{rotating}
- \usepackage{multirow}
- \usepackage{mwe,tikz}
- \usepackage[percent]{overpic}
- \usepackage{enumitem}
- \usepackage{hyperref}
- \newcolumntype{P}[1]{>{\raggedright\arraybackslash}p{#1}}
- \newcommand{\footerDate}{`r params$date`}
- \input{header.tex}
longtable: yes
mainfont: Arial
bibliography: Protocol.bib
params:
  date: '2021-03-20'
  version: 1.0.0
subtitle: 'Version: `r params$version`'
link-citations: true
csl: jamia.csl
---
    
    ```{r setup, include=FALSE}
  knitr::opts_chunk$set(echo = TRUE)
  options(kableExtra.latex.load_packages = FALSE)
  library(kableExtra)
  #knitr::knit_hooks$set(document = function(x) {sub('\\usepackage[]{color}', '\\usepackage[table]{xcolor}', x, fixed = TRUE)})
  library(dplyr)
  options(knitr.kable.NA = "")
  if (!knitr::is_latex_output() && !knitr::is_html_output()) {
    options(knitr.table.format = "simple")
  }
  pdf2png <- function(path) {
    # only do the conversion for non-LaTeX output
    if (knitr::is_latex_output()) {
      return(path)
    }
    path2 <- xfun::with_ext(path, "png")
    img <- magick::image_read_pdf(path)
    magick::image_write(img, path2, format = "png")
    path2
  }
  latex_table_font_size <- 8
  #source("PrintCohortDefinitions.R")
  #numberOfNcs <- nrow(readr::read_csv("../inst/settings/NegativeControls.csv", col_types = readr::cols()))
  ```
  
  # List of Abbreviations
  
  ```{r abbreviations, echo=FALSE, results="asis", warning=FALSE}
  abbreviations <- readr::read_delim(col_names = FALSE, delim = ";", trim_ws = TRUE, file = "
  AUC; Area Under the receiver-operator Curve 
  CCAE; IBM MarketScan Commercial Claims and Encounters 
  CDM; Common Data Model
  CRAN; Comprehensive R Archive Network
  EHR; Electronic Health Record
  IRB; Institutional review board
  JMDC; Japan Medical Data Center
  MDCR; IBM MarketScan Medicare Supplemental Database
  MDCD; IBM MarketScan Multi-State Medicaid Database 
  OHDSI; Observational Health Data Science and Informatics
  OMOP; Observational Medical Outcomes Partnership
")
  tab <- kable(abbreviations, col.names = NULL, linesep = "", booktabs = TRUE)
  if (knitr::is_latex_output()) {
    tab %>% kable_styling(latex_options = "striped", font_size = latex_table_font_size)
  } else {
    tab %>% kable_styling(bootstrap_options = "striped")
  } 
  ```
  
  # Responsible Parties
  
  ## Investigators
  
  ```{r parties, echo=FALSE, results="asis", warning=FALSE}
  parties <- readr::read_delim(col_names = TRUE, delim = ";", trim_ws = TRUE, file = "
  Investigator; Institution/Affiliation
  Jenna Reps *; Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA 
  Jose Posada *; Universidad del Norte, Colombia
  Ross Williams *; Erasmus University
  Aniek Markus *;  Erasmus University
")
  tab <- kable(parties, booktabs = TRUE, linesep = "") %>% 
    column_spec(1, width = "10em") %>%
    column_spec(2, width = "30em") %>%
    footnote(general = "* Principal Investigator", general_title = "")
  if (knitr::is_latex_output()) {
    tab %>% kable_styling(latex_options = "striped", font_size = latex_table_font_size)
  } else {
    tab %>% kable_styling(bootstrap_options = "striped")
  }
  ```
  
  ## Disclosures
  
  This study is undertaken within Observational Health Data Sciences and Informatics (OHDSI), an open collaboration.
  **JMR** is an employee of Janssen Research and Development and shareholders in Johnson & Johnson.
  
  # Abstract
  
  **Background and Significance**
    
  Patient-level prediction models healthcare can help identify a patients personalized risk of some future medical event. These models can aid medical decision making. Machine learning models are frequently published, but few have any clinical impact. One issue limiting models being used clinically is the difficulty with integrating a model into an EHR system (Lee et al, 2020, https://www.mdpi.com/2227-9709/7/3/25). This is a complex task, especially when the model requires variables from different parts of the EHR system. Simple and parsimonious patient level prediction (PLP) models may reduce the complexity of implementing a model clinically. Furthermore, deploying a simple and thus interpretable model can contribute to trustworthy AI in health care (Markus et al., 2021, https://pubmed.ncbi.nlm.nih.gov/33309898/). Interpretability is influenced by amongst others model class and the number of features. In this study we aim to find a data-driven feature selection method to generate parsimonious models that perform well. 
  
  **Study Aims**
    
   We aim to answer the question: Can we find a recommended approach to create parsimonious PLP models for healthcare data?
  
  **Study Description**
    
  * Design: Retrospecive cohort with external validation  
  * Target Populations: 
    1) First random visit in 2017 
    2) First influenza vaccine visit in 2017
  * Outcomes: 
    1) AMI
    2) Anaphylaxis.sql
    3) Appendicitis
    4) DisIntraCoag
    5) Encephalomyelitis
    6) Hemorrhagic Stroke
    7) Non Hemorrhagic Stroke
    8) Pulmonary Embolism
    9) Guillain Barre Syndrome

  * Time-at-risk: 
    1) 1 days to 365 days 
  * Covariates
    1) Demographics (age in 5 year buckets + gender)
    2) Demographics + Conditions + Drugs -1 days to -365 days relative to index
  * Models:
    LASSO Logistic Regression
  * Internal Metrics:
    - Area Under the receiver-operator Curve (AUC).
    - Sensitivity and PPV at a range of thresholds.
    - Calibration Plots  
    - Net Benefit
  * External Metrics:
    - Area Under the receiver-operator Curve (AUC).
    - Sensitivity and PPV at a range of thresholds.
    - Calibration Plots  (pre and post recalibration)
    - Net Benefit (pre and post recalibration)
    


# Amendments and Updates

```{r amendments, echo=FALSE, results="asis", warning=FALSE}
amendments <- readr::read_delim(col_names = TRUE, delim = ";", trim_ws = TRUE, file = "
  Number; Date; Section of study protocol; Amendment or update; Reason
  None;;;; 
")
tab <- kable(amendments, booktabs = TRUE, linesep = "")
if (knitr::is_latex_output()) {
  tab %>% kable_styling(latex_options = "striped", font_size = latex_table_font_size)
} else {
  tab %>% kable_styling(bootstrap_options = "striped")
}
```

# Milestones

```{r dates, echo=FALSE, results="asis", warning=FALSE}
dates <- readr::read_delim(col_names = TRUE, delim = ";", trim_ws = TRUE, file = "
  Milestone; Planned / actual date
  Start of analysis;
  End of analysis;
  Results presentation;
")
tab <- kable(dates, booktabs = TRUE, linesep = "") 
if (knitr::is_latex_output()) {
  tab %>% kable_styling(latex_options = "striped", font_size = latex_table_font_size)
} else {
  tab %>% kable_styling(bootstrap_options = "striped")
}
```

# Rationale and Background

[ADD]


Related/previous work:

Sanchez-Pinto et al. (2018, https://www.sciencedirect.com/science/article/pii/S1386505618305811) analyzed the performance of eight different variable selection methods in two clinical datasets. However, their datasets contained only 29 candidate predictor variables, whereas the number of available variables in healthcare data is typically much larger (ref?). 


# Study Objectives

Can we find a recommended approach to create parsimonious PLP models for healthcare data?

- Is focusing on big data a difference?
- Is focusing on different centers a difference? (different types of data / continents etc.)

Specific aims:
  
To compare different data-driven feature selection methods for simplifying a PLP model.

# Research Methods

## Target Populations

Target 1: Patients with a visit in 2017 with >= 365 days prior observations, index is the first valid visit.

Target 2: Patients with a influenza vaccine in 2017 with >= 365 days prior observations, index is the date of the influenza vaccine.

```{r targets-of-interest, echo=FALSE, warning=FALSE}
eois <- readr::read_csv(system.file("settings", "TargetsOfInterest.csv", package = "CovidVaccinePrediction"), col_types = readr::cols()) %>%
  select(cohortName, cohortDescription)
colnames(eois) <- SqlRender::camelCaseToTitleCase(colnames(eois))
tab <- eois %>%
  kable(booktabs = TRUE, linesep = "",
      caption = "Target Population.") %>% 
  kable_styling(bootstrap_options = "striped", latex_options = "striped")
if (knitr::is_latex_output()) {
  tab %>%
    column_spec(1, width = "8em") %>%
    column_spec(2, width = "18em") %>%
    kable_styling(font_size = latex_table_font_size)
} else {
  tab
}
```


## Outcomes and Time-at-risk

The study will focus on nine outcomes with multiple phenotypes per outcome, as shown in Table \@ref(tab:outcomes-of-interest).

```{r outcomes-of-interest, echo=FALSE, warning=FALSE}
eois <- readr::read_csv(system.file("settings", "OutcomesOfInterest.csv", package = "CovidVaccinePrediction"), col_types = readr::cols()) %>%
  select(outcome, cohortName, cohortDescription, timeAtRisk)
colnames(eois) <- SqlRender::camelCaseToTitleCase(colnames(eois))
tab <- eois %>%
  kable(booktabs = TRUE, linesep = "",
      caption = "Outcome of interest.") %>% 
  kable_styling(bootstrap_options = "striped", latex_options = "striped")
if (knitr::is_latex_output()) {
  tab %>%
    column_spec(1, width = "8em") %>%
    column_spec(2, width = "8em") %>%
    column_spec(3, width = "18em") %>%
    column_spec(4, width = "8em") %>%
    kable_styling(font_size = latex_table_font_size)
} else {
  tab
}
```

## Feature Selection Pipeline

In this study we will compare the following feature selection pipelines:

- Standard LASSO model
- Standard LASSO model + automatic reduction by restricting to top N variables based on feature importance metrics
- Standard LASSO model + automatic reduction with backwards selection afterwards
- Standard LASSO model + automatic reduction with forward selection using LASSO selected variables afterwards
- The constrained LASSO - this lets a user specify the number of variables to include

## Covariates to focus on

- all
- use PHOEBE to select those well represented across databases


## Candidate Covariates

Gender and age in 5-year buckets, conditions in prior 365 days, drugs in prior 365 days.

## Metrics

We will evaluate the performance by calculating the area under the receiver operating characteristic curve for overal discrimination and calibration plots for calibration.  We will also calculate the area under the precision recall curve and net benefit plots.  Threshold dependent performance will be displayed using the probability threshold plot.

Performance will be plotted as a function of number of features in the model to observed the relationship between simplicity and performance. 

## Data sources

We will execute the study as an OHDSI network study.
All data partners within OHDSI are encouraged to participate voluntarily and can do so conveniently, because of the community's shared Observational Medical Outcomes Partnership (OMOP) common data model (CDM) and OHDSI tool-stack.

Many OHDSI community data partners have already committed to participate and we will recruit further data partners through OHDSIs standard recruitment process, which includes protocol publication on OHDSIs GitHub, an announcement in OHDSIs research forum, presentation at the weekly OHDSI all-hands-on meeting and direct requests to data holders.

Table \@ref(tab:data-sources) lists the 5 already committed data sources; these sources encompass a large variety of practice types and populations. 
For each data source, we report a brief description and size of the population it represents.
All data sources will receive institutional review board approval or exemption for their participation before executing the study.

```{r data-sources, echo=FALSE, warning=FALSE}
data_sources <- readr::read_delim(col_names = TRUE, delim = ";", trim_ws = TRUE, file = "
  Data source ; Population ; Patients ; History ; Data capture process and short description
  IBM MarketScan Commercial Claims and Encounters (CCAE) ; Commercially insured, < 65 years ; 142M ; 2000 -- ; Adjudicated health insurance claims (e.g. inpatient, outpatient, and outpatient pharmacy)  from large employers and health plans who provide private healthcare coverage to employees, their spouses and dependents.
  IBM MarketScan Medicare Supplemental Database (MDCR)  ; Commercially insured, 65$+$ years ; 10M ; 2000 -- ; Adjudicated health insurance claims of retirees with primary or Medicare supplemental coverage through privately insured fee-for-service, point-of-service or capitated health plans.
  IBM MarketScan Multi-State Medicaid Database (MDCD) ; Medicaid enrollees, racially diverse ; 26M ; 2006 -- ; Adjudicated health insurance claims for Medicaid enrollees from multiple states and includes hospital discharge diagnoses, outpatient diagnoses and procedures, and outpatient pharmacy claims.
  Optum Clinformatics Data Mart (Optum) ; Commercially or Medicare insured ; 85M ; 2000 -- ; Inpatient and outpatient healthcare insurance claims.
  Optum Electronic Health Records (OptumEHR) ; US, general ; 93M ; 2006 -- ; Clinical information, prescriptions, lab results, vital signs, body measurements, diagnoses and procedures derived from clinical notes using natural language processing. 
")
tab <- kable(data_sources, booktabs = TRUE, linesep = "",
      caption = "Committed  data sources and the populations they cover.") %>% 
  kable_styling(bootstrap_options = "striped", latex_options = "striped") %>%
  pack_rows("Administrative claims", 1, 4, latex_align = "c", indent = FALSE) %>%
  pack_rows("Electronic health records (EHRs)", 5, 5, latex_align = "c", indent = FALSE)
if (knitr::is_latex_output()) {
  tab %>%
    column_spec(1, width = "10em") %>%
    column_spec(2, width = "10em") %>%
    column_spec(5, width = "25em") %>%
    kable_styling(font_size = latex_table_font_size)
} else {
  tab
}
```


# Strengths and Limitations

## Strengths

- We follow the PatientLevelPrediction framework for developing and evaluating models to ensure best practices are applied
- Our standardized framework enables us to externally validate our models accross a large number of external databases 
- The fully specified study protocol is being published before analysis begins.
- All analytic methods have previously been verified on real data.
- All software is freely available as open source.
- Use of a common data model allows extension of the experiment to future databases and allows replication of these results on licensable databases that were used in this experiment, while still maintaining patient privacy on patient-level data.

## Limitations

- We are unable to test our models in a clinical setting
- In a clinically setting predictors may be self reported and these may differ from our covariate definitions
- The electronic health record databases may be missing care episodes for patients due to care outside the respective health systems.

# Protection of Human Subjects

This study does not involve human subjects research.
The project does, however, use de-identified human data collected during routine healthcare provision.
All data partners executing the study within their data sources will have received institutional review board (IRB) approval or waiver for participation in accordance to their institutional governance prior to execution (see Table \@ref(tab:irb)).
This study executes across a federated and distributed data network, where analysis code is sent to participating data partners and only aggregate summary statistics are returned, with no sharing of patient-level data between organizations.

```{r irb, echo=FALSE,warning=FALSE}
data_sources <- readr::read_delim(col_names = TRUE, delim = "&", trim_ws = TRUE, file = "
Data source & Statement
IBM MarketScan Commercial Claims and Encounters (CCAE) & New England Institutional Review Board and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research.
IBM MarketScan Medicare Supplemental Database (MDCR)  & New England Institutional Review Board and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research.
IBM MarketScan Multi-State Medicaid Database (MDCD) & New England Institutional Review Board and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research.
Japan Medical Data Center (JMDC) & New England Institutional Review Board and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research.
Optum Clinformatics Data Mart (Optum) & New England Institutional Review Board and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research.
Optum Electronic Health Records (OptumEHR) & New England Institutional Review Board and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research.
")
tab <- kable(data_sources, booktabs = TRUE, linesep = "",
      caption = "IRB approval or waiver statement from partners.") %>% 
  kable_styling(bootstrap_options = "striped", latex_options = "striped")
if (knitr::is_latex_output()) {
  tab %>%
    column_spec(1, width = "15em") %>%
    column_spec(2, width = "40em") %>%
    kable_styling(font_size = latex_table_font_size)
} else {
  tab
}
```

# Plans for Disseminating and Communicating Study Results

Open science aims to make scientific research, including its data process and software, and its dissemination, through publication and presentation, accessible to all levels of an inquiring society, amateur or professional [@Woelfle2011-ss] and is a governing principle of this study.
Open science delivers reproducible, transparent and reliable evidence.
All aspects of this study (except private patient data) will be open and we will actively encourage other interested researchers, clinicians and patients to participate.
This differs fundamentally from traditional studies that rarely open their analytic tools or share all result artifacts, and inform the community about hard-to-verify conclusions at completion.

## Transparent and re-usable research tools

We will publicly register this protocol and announce its availability for feedback from stakeholders, the OHDSI community and within clinical professional societies.
This protocol will link to open source code for all steps to generate and evaluate prediction models, figures and tables.
Such transparency is possible because we will construct our studies on top of the OHDSI toolstack of open source software tools that are community developed and rigorously tested [@Schuemie2020-wx].
We will publicly host the source code at (https://github.com/ohdsi-studies/FeatureSelectionComparison), allowing public contribution and review, and free re-use for anyoneâ€™s future research.

## Scientific meetings and publications

We will deliver multiple presentations at scientific venues and will also prepare multiple scientific publications for clinical, informatics and statistical journals.

## General public

We believe in sharing our findings that will guide clinical care with the general public.
We will use social-media (Twitter) to facilitate this.


